Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE
Sign Up
Log in
Xeris Biopharma Holdings Inc banner

Xeris Biopharma Holdings Inc
F:2B30

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
F:2B30
Watchlist
Price: 5.4 EUR 2.86% Market Closed
Market Cap: €800.6m
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for Xeris Biopharma Holdings Inc (2B30) under the Base Case is 5.57 EUR. Compared with the current market price of 5.4 EUR, the stock appears Undervalued by 3% .

Based on two methods:
DCF Value
€5.74
Multiples-Based Value
€5.39
DCF Value
€5.74
Multiples-Based Value
€5.39

DCF suggests undervaluation, while multiples suggest overvaluation.

2B30 Intrinsic Value
5.57 EUR
Undervaluation 3%
Intrinsic Value
Price €5.4
Bear Case
Base Case
Bull Case
Monitor 2B30
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €4.45
Get notified when the price drops into your buy zone
Intrinsic Value €5.57
Current Price €5.4
Margin of Safety 20% €4.45
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
What is Valuation History?
Ask AI Assistant
What other research platforms think about 2B30?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 2B30 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Xeris Biopharma Holdings Inc.

Explain Valuation
Alternatives to 2B30

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Xeris Biopharma Holdings Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

XERS Insider Trading
Buy and sell transactions by insiders

See Also

Summary
2B30 intrinsic value, competitors valuation, and company profile.
DCF Valuation
2B30 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2B30 stock valuation using valuation multiples.
Wall St Estimates
2B30 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2B30 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Xeris Biopharma Holdings Inc listings:
NASDAQ • USD
XERS
 LSE • USD
0A8E
Discover More
What is the Intrinsic Value of one 2B30 stock?

The intrinsic value for Xeris Biopharma Holdings Inc (2B30) under the Base Case is 5.57 EUR.

Is 2B30 stock undervalued or overvalued?

Compared with the current market price of 5.4 EUR, the stock appears Undervalued by 3% .

Back to Top
ALPHA SPREAD
Follow us
Join 337,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett